[go: up one dir, main page]

FR3017799B1 - Composition comestiblepour le traitement de la phase de debut du syndrome depressif - Google Patents

Composition comestiblepour le traitement de la phase de debut du syndrome depressif

Info

Publication number
FR3017799B1
FR3017799B1 FR1400468A FR1400468A FR3017799B1 FR 3017799 B1 FR3017799 B1 FR 3017799B1 FR 1400468 A FR1400468 A FR 1400468A FR 1400468 A FR1400468 A FR 1400468A FR 3017799 B1 FR3017799 B1 FR 3017799B1
Authority
FR
France
Prior art keywords
depression
phase
treatment
combinable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1400468A
Other languages
English (en)
Other versions
FR3017799A1 (fr
Inventor
Constant Thomaoglou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otx Solutions Lu
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1400468A priority Critical patent/FR3017799B1/fr
Priority to LU92643A priority patent/LU92643B1/fr
Priority to BE2015/5038A priority patent/BE1023296B1/fr
Priority to US15/120,838 priority patent/US20160361272A1/en
Priority to EP15707544.1A priority patent/EP3110413A1/fr
Priority to PCT/EP2015/000404 priority patent/WO2015124318A1/fr
Publication of FR3017799A1 publication Critical patent/FR3017799A1/fr
Application granted granted Critical
Publication of FR3017799B1 publication Critical patent/FR3017799B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1400468A 2014-02-24 2014-02-24 Composition comestiblepour le traitement de la phase de debut du syndrome depressif Expired - Fee Related FR3017799B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1400468A FR3017799B1 (fr) 2014-02-24 2014-02-24 Composition comestiblepour le traitement de la phase de debut du syndrome depressif
LU92643A LU92643B1 (fr) 2014-02-24 2015-01-27 Composition comestible pour le traitement de la phase de début du syndrome dépressif
BE2015/5038A BE1023296B1 (fr) 2014-02-24 2015-01-27 Composition comestible pour le traitement de la phase de debut du syndrome depressif
US15/120,838 US20160361272A1 (en) 2014-02-24 2015-02-23 Edible composition including safranal, crocin, picrocrocin and a vitamin b complex for treating the initial phase of depression
EP15707544.1A EP3110413A1 (fr) 2014-02-24 2015-02-23 Composition comestible comprenant du safranal, de la crocine, de la picrocrocine et un complexe vitaminique b, pour le traitement de la phase de debut du syndrome depressif
PCT/EP2015/000404 WO2015124318A1 (fr) 2014-02-24 2015-02-23 Composition comestible comprenant du safranal, de la crocine, de la picrocrocine et un complexe vitaminique b, pour le traitement de la phase de debut du syndrome depressif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1400468A FR3017799B1 (fr) 2014-02-24 2014-02-24 Composition comestiblepour le traitement de la phase de debut du syndrome depressif

Publications (2)

Publication Number Publication Date
FR3017799A1 FR3017799A1 (fr) 2015-08-28
FR3017799B1 true FR3017799B1 (fr) 2017-02-10

Family

ID=51063494

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1400468A Expired - Fee Related FR3017799B1 (fr) 2014-02-24 2014-02-24 Composition comestiblepour le traitement de la phase de debut du syndrome depressif

Country Status (6)

Country Link
US (1) US20160361272A1 (fr)
EP (1) EP3110413A1 (fr)
BE (1) BE1023296B1 (fr)
FR (1) FR3017799B1 (fr)
LU (1) LU92643B1 (fr)
WO (1) WO2015124318A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2573542B1 (es) * 2016-04-18 2017-03-13 Pharmactive Biotech Products, S.L. Empleo de un nuevo extracto de azafrán para la prevención de trastornos del estado de ánimo relacionados con la depresión
FR3054443B1 (fr) 2016-07-28 2020-01-03 Activ'inside Extrait de plante tres concentre en safranal, procede d'obtention et utilisations
WO2019077621A1 (fr) * 2017-10-16 2019-04-25 Council Of Scientific And Industrial Research Formulations à libération prolongée de crocus sativus
FR3078628B1 (fr) * 2018-03-09 2020-03-27 Id Phar Composition comestible sous forme de gelule pour la prevention de troubles de l’humeur
IT201900002457A1 (it) * 2019-02-20 2020-08-20 Neuraxpharm Italy S P A Composizione per prevenire e trattare sintomi depressivi e cognitivi
CN114431385A (zh) * 2022-02-18 2022-05-06 杭州康馨宏生物技术有限公司 一种含西红花的固体饮料、制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT411958B8 (de) * 1998-11-19 2004-09-27 Jhs Privatstiftung Erfrischungsgetränk zur steigerung der alkohol-abbau-kapazität
FR2900053B1 (fr) * 2006-04-25 2012-11-16 Cedric Bourges Utilisation du safranal, de la crocine, de la picrocrocine et leurs derives en tant qu'agent de satiete pour le traitement de la surcharge ponderale

Also Published As

Publication number Publication date
BE1023296B1 (fr) 2017-01-26
US20160361272A1 (en) 2016-12-15
WO2015124318A1 (fr) 2015-08-27
FR3017799A1 (fr) 2015-08-28
EP3110413A1 (fr) 2017-01-04
LU92643B1 (fr) 2016-07-11
BE1023296A1 (fr) 2017-01-26

Similar Documents

Publication Publication Date Title
DK3364993T3 (da) Fremgangsmåder til behandling af angelman syndrom
EP3615010A4 (fr) Méthodes de traitement du syndrome de dravet
HUE059041T2 (hu) Eljárás KIT-tel összefüggõ rendellenességek kezelésére alkalmas kompozíciók elõállítására
DK3998070T3 (da) Mir-124 som biomarkør til behandling af inflammatoriske sygdomme
DK3076967T3 (da) Fremgangsmåder til behandling af residuelle symptomer på skizofreni
BR112016025246A2 (pt) composição de preservativo de madeira
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
EP3331550A4 (fr) Procédés de traitement de syndrome myéloprolifératif
EP3314504A4 (fr) Techniques de fonctionnement distribué de contrôleurs sécurisés
HUE059158T2 (hu) Eljárás pridopidin elõállítására
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
IL248223A0 (en) Vaccine compositions
DK3666258T3 (da) Fremgangsmåde til behandling af prader-willis syndrom
FR3017799B1 (fr) Composition comestiblepour le traitement de la phase de debut du syndrome depressif
HRP20181570T1 (hr) Režim doziranja spoja fgf-18
DK3188727T3 (da) Tasimelteon til behandling af smith-magenis¿ syndrom
HUE047756T2 (hu) Eljárás metil-merkaptán elõállítására
HUE045704T2 (hu) Eljárás 5-fluor-1H-pirazolok elõállítására hexafluorpropénbõl kiindulva
DK3122349T3 (da) Sammensætninger til behandling af autodigestion
DK3524260T3 (da) Farmaceutiske sammensætninger til behandling af manglende appetit
DK3578179T3 (da) Process for the preparation of cyclic depsipeptides
MA42444A (fr) Traitement du prurit
EP3311767A4 (fr) Instrument de traitement haute fréquence

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLFP Fee payment

Year of fee payment: 3

TP Transmission of property

Owner name: OTX SOLUTIONS, LU

Effective date: 20160513

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20181031